drugset / Trial / NCT01394263
Study of Histrelin Subdermal Implant in Patients With Prostate Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial was an open-label, multi-national, randomized, parallel treatment, active-control multicenter study in adult males with documented metastatic prostate cancer disease who were judged to be candidates for hormone therapy.
Timeline
- Start
- 2000-05
- Primary completion
- 2001-12
- Completion
- 2003-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Goserelin | Other / unclassified | 10.8 mg | Subcutaneous |
| Subject | Histrelin | Other / unclassified | 50 mg | Other |